APRICOT BIO MILESTONES
APRICOT BIO MILESTONES
Stay informed with the latest updates on our company and platform. We are committed to keeping our clients and partners up to date on our progress, innovations, and the continued growth of our project.
LATEST NEWS
28 May 2025
Feasibility of multi-omics tumor profiling for guiding treatment of melanoma - Nature Medicine
In a landmark study, which incorporated the 4iDRP platform, the feasibility and relevance of omics-based tumor profiling to support data-guided clinical decision-making was demonstrated, paving the way to a new era of predictive personalized medicine
6 May 2025
Apricot BIO participates in Venture Leaders Biotech 2025 Kickoff at Swiss Biotech Day ahead of Boston roadshow
An impactful 3 days in Basel - > 3'000 participants, ca. 45% joining from abroad, including 25 international delegations. The biggest and most international edition so far.
18 November 2024
Apricot BIO signs 2-year ovarian cancer trial with OV Precision, an interventional clinical trial incorporating precision medicine.
28 September 2023
4i Platform empowers AI models based on neural optimal transport to achieve unprecedented accuracy in predicting drug responses of single cells
“Learning single-cell perturbation responses using neural optimal transport”
29 May 2023
4i platform empowers deep learning of subcellular organization
“Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps”
Highly multiplexed imaging holds enormous promise for understanding how spatial context shapes the activity of the genome and its products at multiple length scales.
8 May 2023
4i platform enables spatial multi-omics on tissue sections
“Multimodal spatiotemporal phenotyping of human retinal organoid development”
In this study, the team generated multiplexed protein maps over a retinal organoid time course and primary adult human retinal tissue. We developed a toolkit to visualize progenitor and neuron location, the spatial arrangements of extracellular and subcellular components and global patterning in each organoid and primary tissue.
18 December 2022
First proof-of-concept partner signed
25 October 2022
Speaker at Samsung Global Research Symposium
18 October 2022
Speaker at the Allen Institute for Cell Science
4 October 2022
Options agreement signed with University of Zurich (UZH) for exclusivity on 2 patent families for 4iDRP
The basis of IP for Apricot BIO is agreed with University of Zurich and Unitectra, solidifying a key foundation for the company. We are grateful for the collaboration with UZH and look forward to many more milestones together.
6 September 2022
The birth of Apricot !
Registered and open for business
14 July 2022
Breakthrough study using 4i published
“Multimodal perception links cellular state to decision-making in single cells”
Individual cells make decisions that are adapted to their internal state and surroundings, but how cells can reliably do this remains unclear. To study the information processing capacity of human cells, we conducted multiplexed quantification of signaling responses and markers of the cellular state.
26 June 2022
First steps towards the founding of Apricot
13 August 2018
The method of 4i is published
Ground breaking paper is published in Science - Being able to visualize protein localizations within cells and tissues by means of immuno-fluorescence microscopy has been key to developments in cell biology and beyond. Gut et al. present a high-throughput method that achieves the detection of more than 40 different proteins in biological samples across multiple spatial scales.
Obtaining highly multiplexed protein measurements across multiple length scales has enormous potential for biomedicine.